10-K: AiXin Life International Reports Fiscal Year 2023 Results, Revenue Up 51%

AiXin Life International saw a 51% increase in revenue for fiscal year 2023, driven by growth in product sales, pharmacies, and hotel operations.

Summary

• AiXin Life International reported a 51% increase in revenue for fiscal year 2023, reaching $4,089,799, compared to $2,708,560 in 2022.
• The revenue growth was primarily due to increased direct sales of nutritional products, higher revenues from the hotel and pharmacies, and the inclusion of revenue from Runcangsheng, acquired in September 2022.
• Direct product sales increased by 41% to $1,159,134, while pharmacy revenue rose by 19% to $937,655.
• Hotel revenue saw a 39% increase to $1,194,829, and revenue from manufacturing and sales, primarily from Runcangsheng, increased by 235% to $798,181.
• The company's operating loss decreased slightly to $2,498,807 in 2023 from $2,569,459 in 2022.
• The net loss for 2023 was $2,090,694, a significant decrease from the $6,369,245 net loss in 2022, primarily due to increased sales and the absence of an impairment loss.
• The company used $1,392,259 in operating activities during 2023 and had a working capital deficit of $4,467,006 as of December 31, 2023.
• Cash and cash equivalents were $443,758 as of December 31, 2023, compared to $510,128 at the end of 2022.

Sentiment

Score: 5

Explanation: The document presents mixed signals. While revenue growth is strong, the company is still operating at a loss and has a significant working capital deficit. The risks outlined are substantial, suggesting a cautious outlook.

Positives

• The company experienced significant revenue growth across all segments.
• The net loss decreased substantially year-over-year.
• The company's pharmacies saw a decrease in the cost of goods sold as a percentage of sales.
• The company's hotel revenue increased due to increased travel and consumption activities in China after the pandemic.
• The company's manufacturing and sales segment saw a large increase in revenue due to the inclusion of Runcangsheng.

Negatives

• The company continues to operate at a loss.
• The company has a working capital deficit of $4,467,006 as of December 31, 2023.
• The company used $1,392,259 in operating activities during 2023.
• The company's direct product sales saw an increase in the cost of goods sold as a percentage of sales due to increased commission payouts to sales personnel.

Risks

• The company operates in a highly competitive industry and may lose market share to competitors.
• The company has a limited operating history and may not be able to sustain its growth.
• The company's expansion plans are subject to uncertainties and risks.
• The company's ability to anticipate consumer preferences could negatively impact demand for its products.
• The company may incur material product liability claims or experience product recalls.
• The company's ability to protect its brand names and reputation could be impacted by unfavorable publicity.
• The company relies on third parties for various services, and the loss of any of these could harm its business.
• The company is subject to numerous regulations, and compliance could increase costs.
• The company depends on a limited number of suppliers for raw materials.
• The company's business may be materially adversely affected by global geopolitical conditions.
• The company may be impacted by its ability to attract, develop and retain qualified associates and manage labor-related costs.
• The company's insurance may not be sufficient.
• The company's key executive does not devote his full business time to the company's operations.
• The company's principal shareholder is not familiar with American business practices.
• The company may be adversely impacted by certain compliance or legal matters.
• The company's common stock may be delisted under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect its auditors.
• The company could be subject to conflicting demands placed upon it by regulatory authorities in the United States and the PRC.
• The company is exposed to liabilities relating to environmental protection and safety laws and regulations.
• The company may require additional financing and its operations could be curtailed if it is unable to obtain required additional financing when needed.
• The PRC government has significant oversight and discretion over the conduct of a PRC company's business operations.
• The company may have difficulty in effecting service of legal process or bringing actions in China against it or its management based on foreign laws.
• The company may have difficulty in enforcing foreign judgements in China against it or its management.
• Foreign exchange fluctuations may affect the company's business.
• Inflation could pose a risk to the company's business.
• Changes in the policies, regulations, rules and the enforcement of laws of the PRC government may be quick with little advance notice and could have a significant impact upon the business the company may be able to conduct in the PRC and the profitability of such business.
• There are uncertainties regarding the interpretation and enforcement of PRC laws, rules and regulations.
• PRC regulations regarding acquisitions impose significant regulatory approval and review requirements, which could make it more difficult for the company to pursue growth through acquisitions.
• The company's business may be subject to a variety of PRC laws and other obligations regarding cybersecurity and data protection.
• PRC regulations relating to investments in offshore companies by PRC residents may subject the company's PRC-resident beneficial owners or its PRC Subsidiaries to liability or penalties.
• The company may be treated as a resident enterprise for PRC tax purposes under the PRC Enterprise Income Tax Law, and it may therefore be subject to PRC income tax on its global income.
• Restrictions on currency exchange may limit the company's ability to utilize its PRC revenue effectively.
• Fluctuations in foreign exchange rates will impact the company's reported results.
• The disclosures in the company's reports and other filings with the SEC and its other public pronouncements are not subject to the scrutiny of any regulatory bodies in the PRC.
• Introduction of new laws or changes to existing laws by the PRC government may adversely affect the company's business.
• Substantial uncertainties exist with respect to the interpretation and implementation of the newly enacted Foreign Investment Law and how it may impact the viability of the company's current corporate structure, corporate governance and business operations.
• The company may rely on dividends and other distributions on equity paid by its PRC Subsidiaries to fund any cash and financing requirements it may have, and any limitation on the ability of its PRC Subsidiaries to make payments to it could have a material and adverse effect on its ability to conduct its business.
• PRC regulation of loans to and direct investment in PRC entities by offshore holding companies and governmental control of currency conversion may delay or prevent the company from making loans or additional capital contributions to its PRC Subsidiaries.
• There is a limited public market for the company's common stock and you may not be able to resell its shares at or above the price you paid or at all.
• The market price of the company's shares is likely to be highly volatile, which could result in substantial losses to investors.
• The sale or availability for sale of substantial amounts of the company's common stock could adversely affect its market price.
• If securities or industry analysts do not publish research or reports about the company's business, or if they adversely change their recommendations regarding its common stock, the market price for its common stock and trading volume could decline.
• Because the company does not expect to pay dividends in the foreseeable future, you must rely on price appreciation of its common stock for return on your investment.
• The company's CEO has substantial influence over the company. His interests may not be aligned with the interests of its other shareholders, and he could prevent or cause a change of control or other transactions.
• The concentration in the ownership of the company's common stock shares may cause a material decline in the value of its common stock.

Future Outlook

The company intends to explore opportunities to expand its product line, acquire additional pharmacies and retail outlets, and potentially operate nursing homes and clinics. The company also plans to use its new hotel to host events and educate team members and customers.

Management Comments

• The company believes its multi-channel distribution model, combined with its research, development and manufacturing capabilities offers a unique advantage over its competitors.
• The company believes that its proactive approach to marketing, reaching out to customers to provide information as to how to live a healthy lifestyle, is ideally suited to marketing health and wellness products.
• The company intends to seek to continue to expand its chain of pharmacies and to use these outlets as part of its overall marketing strategy.

Industry Context

The company operates in the competitive health and wellness market in China, which is characterized by various channels including direct selling, online, specialty retailers, pharmacies, and discount channels. The company seeks to differentiate itself through personalized sales experiences, after-sale services, and a focus on product education.

Comparison to Industry Standards

• The company competes with large pharmaceutical and food companies, as well as other brands, some of which have greater market presence, name recognition and financial, marketing and other resources.
• The company's omni-channel approach is a differentiator compared to competitors that rely exclusively on online marketing.
• The company's vertical integration, including research, development, and manufacturing capabilities, is a competitive advantage.
• The company's focus on personal coaching, education, and product access provided by its sales employees is a differentiator in the market.

Legal Proceedings

• The company is involved in a legal proceeding related to a purchase agreement breach by a subsidiary, which occurred before the subsidiary was acquired by the company.
• The company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.

Related Party Transactions

• The company has various transactions with related parties, including advances to and from entities controlled by its CEO and other directors.
• The company has a lease agreement with its major shareholder for office space.
• The company has a lease agreement with the wife of a director for office space.

Stakeholder Impact

• Shareholders face risks due to the company's operating losses, working capital deficit, and potential need for additional financing.
• Employees may be impacted by the company's ability to manage labor costs and retain qualified personnel.
• Customers may benefit from the company's focus on product quality and personalized service.
• Suppliers may be impacted by the company's reliance on a limited number of suppliers and its ability to pay for goods and services.
• Creditors face risks due to the company's financial condition and potential need for additional financing.

Next Steps

• The company intends to explore opportunities to expand its product line through internal research and acquisitions.
• The company plans to acquire additional pharmacies and other retail outlets.
• The company will explore operating nursing homes and possibly clinics.
• The company will continue to develop well-trained team members that work closely with customers.
• The company will continue to use loyalty programs to develop and maintain a large and loyal customer base.

Key Dates

Keywords

nutritional products, pharmacies, hotel, health and wellness, China, Runcangsheng, direct marketing, omni-channel, financial results, revenue growth